Xianyang Zhu

ORCID: 0000-0003-1372-9143
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Congenital Heart Disease Studies
  • Pulmonary Hypertension Research and Treatments
  • Cardiovascular and Diving-Related Complications
  • Cardiovascular Conditions and Treatments
  • Cardiac Valve Diseases and Treatments
  • Coronary Artery Anomalies
  • Cardiovascular Issues in Pregnancy
  • Cardiac Arrhythmias and Treatments
  • Vascular anomalies and interventions
  • Cardiac Structural Anomalies and Repair
  • Cardiac tumors and thrombi
  • Congenital heart defects research
  • Atrial Fibrillation Management and Outcomes
  • Cardiovascular Function and Risk Factors
  • Tracheal and airway disorders
  • Infective Endocarditis Diagnosis and Management
  • Aortic Disease and Treatment Approaches
  • Congenital Diaphragmatic Hernia Studies
  • Tissue Engineering and Regenerative Medicine
  • Platelet Disorders and Treatments
  • Electrospun Nanofibers in Biomedical Applications
  • Heart Failure Treatment and Management
  • Vascular Anomalies and Treatments
  • Health Systems, Economic Evaluations, Quality of Life
  • Mesenchymal stem cell research

General Hospital of Shenyang Military Region
2015-2025

Mayo Clinic
2022

Shenyang 242 Hospital
2010-2017

China Pharmaceutical University
2015

Northern Hospital
2013

Jinzhou Medical University
2012

Chinese Academy of Medical Sciences & Peking Union Medical College
2011

Chinese PLA General Hospital
2007

10.1016/s2213-2600(24)00027-4 article EN The Lancet Respiratory Medicine 2024-03-26
R. James White Carlos Jerjes‐Sánchez G. Meyer Tomás Pulido Pablo Sepúlveda and 95 more Kuo Yang Wang Ekkehard Grünig Shirish Hiremath Zaixin Yu Gangcheng Zhang Wei Luen James Yip Shuyang Zhang Akram Khan C. Q. Deng R. Grover Victor F. Tapson Graciela Svetliza Adrián Lescano Guillermo Bortman Fabián Diez Christian Edgardo Botta John E. Fitzgerald Eelke Feenstra F. Kermeen Anne Keogh Trevor J. Williams Peter Paul Yousseff Benjamin Ng David M. Smallwood Nathan Dwyer M. Brown Iréne Lang Regina Steringer‐Mascherbauer Jaquelina Sonoe Ota Arakaki Frederico Thadeu Assis Figueiredo Campos Ricardo de Amorim Corrêa Rogério Souza G. Meyer Maria Auxiliadora Carmo Moreira Hugo Hyung Bok Yoo Mônica Silveira Lapa John R. Swiston Naushad Hirani Sanjay Mehta Evangelos D. Michelakis Pablo Sepúlveda Monica Maria Zagolin Blancaire Jimming Liu Shuyang Zhang Lei Pan Chunde Bao Qun Yi Xiaoshu Cheng Yu Zaixin Xinli Li Hua Yao Gangcheng Zhang Xianyang Zhu Yundai Chen Zhaozhong Cheng Yuanhua Yang Zhou Daxin Jie-yan Shen Jens Erik Nielsen‐Kudsk Jørn Carlsen Arnaud Bourdin É. Hachulla Claire Dromer Ari Chaouat Martine Reynaud-Gauber Marie‐France Seronde Hans Klose Michael Halank G. Höffken Ralf Ewert Stephan Rosenkranz Ekkehard Grünig Ulrich Krüger Juliane Kronsbein B. Hauptmeier Andrea Koch Matthias Held Tobias Lange C Neurohr Heinrike Wilkens Hubert Wirtz Stavros Konstantinides Paraskevi Argyropoulou-Pataka Stylianos E. Orfanos Shirish Hiremath Prafulla Kerkar Pujar Venkateshacharya Suresh Hemang Baxi Abraham Oomman Rajpal K. Abhaichand Padma Kumar Edla Arjun Vijay Chopra Rahul Mehrotra Rajeev Kumar Rajput J.P.S. Sawhney

Rationale: Oral treprostinil improves exercise capacity in patients with pulmonary arterial hypertension (PAH), but the effect on clinical outcomes was unknown.Objectives: To evaluate of oral compared placebo time to first adjudicated worsening event participants PAH who recently began approved monotherapy.Methods: In this event-driven, double-blind study, we randomly allocated 690 (1:1 ratio) receive or extended-release tablets three times daily. Eligible were using monotherapy for over 30...

10.1164/rccm.201908-1640oc article EN cc-by-nc-nd American Journal of Respiratory and Critical Care Medicine 2019-11-25

Abstract Background and objective Nationally representative reports on the characteristics long‐term survival of pulmonary arterial hypertension (PAH) from developing countries are scarce. The applicability current main risk stratifications longitudinal changes in goal‐oriented treatments have yet to be elucidated real‐world settings. Therefore, we aimed provide insights into characteristics, PAH China explore our independent cohort. Methods patients were consecutively enrolled a national...

10.1111/resp.14247 article EN Respirology 2022-03-15

Adipose-derived stem cells (ADSCs) are capable of differentiating into cardiomyogenic and endothelial in vitro. We tested the hypothesis that transplantation ADSCs myocardial scar may regenerate infracted myocardium restore cardiac function.ADSCs were isolated from fatty tissue New Zealand white rabbits cultured Iscoves modified dulbeccos medium. Three weeks after ligation left anterior descending coronary artery rabbits, either a graft untreated (UASCs, n = 14), 5-azacytidine-pretreated...

10.1097/00029330-200702020-00009 article EN cc-by-nc-nd Chinese Medical Journal 2007-02-01

Abstract Objective: To assess the feasibility of transcatheter closure in patients with dextrocardia and isolated atrial septal defect or ventricular defect. Methods: A retrospective analysis was performed on clinical data 10 from June 2013 to January 2023 successfully underwent closure. Patient were meticulously collected. Results: The study cohort comprised patients, three males, aged between 3 38 years. Intraoperative right heart catheterisation revealed following measurements: mean...

10.1017/s1047951125000320 article EN Cardiology in the Young 2025-02-03

Background The next-generation closure device for interventional treatment of patent foramen ovale (PFO) is regarded as biodegradable, yet the corresponding biomaterial technique still challenging. Herein, we report clinical application a novel biodegradable PFO occluder [made material polydioxanone (PDO)] that finally coming into use. Objectives This study aimed to assess safety and efficacy Pansy® (Mallow Medical, Shanghai, China) in patients exhibiting with substantial right-to-left shunt...

10.3389/fcvm.2025.1464712 article EN cc-by Frontiers in Cardiovascular Medicine 2025-04-04

To assess the immediate and long-term outcomes of transcatheter closure ventricular septal defect (VSD) in combination with percutaneous coronary intervention (PCI) patients VSD complicating acute myocardial infarction (AMI).Data were prospectively collected from 35 AMI who underwent attempted PCI therapy five high-volume heart centres. All survived procedures followed up by chest x-ray, electrocardiogram echocardiography. Thirteen urgent phase (within two weeks VSD) while others elective at...

10.4244/eijv8i11a195 article EN EuroIntervention 2013-03-01

Transcatheter closure of coronary artery fistulae (CAF) has emerged as an alternative to surgery, but there are no long-term outcome results.We report immediate and results in 24 patients after transcatheter congenital CAF.A total aged 5 56 years old with CAF underwent attempted percutaneous using various devices between November 1998 August 2008. The clinical follow-up were reviewed.Of the patients, 20 (83.3%) successful devices. An angiogram right device deployment revealed complete...

10.1002/clc.20650 article EN Clinical Cardiology 2009-09-01

No method is available to predict whether patients with patent ductus arteriosus (PDA) and severe pulmonary arterial hypertension (PAH) will show persistent postprocedural PAH (PP-PAH) after PDA closure. This study evaluated the usefulness of trial occlusion for predicting PP-PAH transcatheter closure in PAH.Trial was performed 137 (age ≥12 years) PAH. All undergoing had a mean artery pressure ≥45 mm Hg, pulmonary:systemic flow (Qp/Qs) ratio >1.5, resistance (Rp/Rs) <0.7. A total 135 (98%)...

10.1161/circinterventions.113.001135 article EN Circulation Cardiovascular Interventions 2014-08-01

We investigated the acute vasodilator effects of i.v. fasudil, a specific Rho-kinase inhibitor, on pulmonary circulation in patients with congenital heart defects (CHD) and severe arterial hypertension (PAH).Thirty-five (34.23±12.10 years old) CHD PAH were consecutively enrolled. All underwent catheterization. At baseline 30 min after initiation following hemodynamic parameters measured calculated: right atrial pressure, systemic artery pressure (PAP SAP), vascular resistance,...

10.1253/circj.cj-14-1015 article EN Circulation Journal 2015-01-01

AimsCardiac structural genes have been implicated as causative factors for congenital heart diseases (CHDs). NEXN is an F-actin binding protein and previously identified a disease gene causing cardiomyopathies. Whether contributes to CHDs aetiologically remains unknown. Here, we explored the function of in cardiac development.

10.1093/cvr/cvu134 article EN Cardiovascular Research 2014-05-27

We retrospectively reported our 26-year experience with operative repair of total anomalous pulmonary venous connection (TAPVC) biventricular physiology.Between December 1982 and 2008, 122 TAPVC patients heart underwent surgical in department. Moderate or deep hypothermia was induced at the time cardiopulmonary bypass (CPB). Follow-up conducted for 5 postoperative years. Surgical outcomes early intermediate deaths after were analyzed.Six occurred operatively; three deaths, during follow-up....

10.1186/s13019-015-0387-6 article EN cc-by Journal of Cardiothoracic Surgery 2015-11-24

BACKGROUND:Use of renin-angiotensin-aldosterone system inhibitors in coronavirus disease 2019 (COVID-19) patients lacks evidence and is still controversial. This study was designed to investigate effects angiotensin-converting enzyme (ACEIs) or angiotensin II receptor blockers (ARBs) on clinical outcomes COVID-19 assess the safety ACEIs/ARBs medication. MATERIAL AND METHODS:COVID-19 with hypertension from 2 hospitals Wuhan, China, 17 Feb 18 Mar 2020 were retrospectively screened grouped...

10.12659/msm.926651 article EN Medical Science Monitor 2020-08-10

It has been demonstrated that sildenafil is effective in patients with pulmonary arterial hypertension (PAH). However, the impact of on PAH adults congenital heart disease (CHD) less investigated.In this prospective, open-label, uncontrolled and multicenter study, 60 related to CHD received oral (75 mg/day) for 12 weeks. The enrolled underwent six-minute walk test (SMWT) cardiac catheterization at beginning end primary point was changes exercise capacity assessed by SMWT; secondary included...

10.1111/j.1755-5922.2010.00213.x article EN Cardiovascular Therapeutics 2010-07-19

Objective To evaluate the clinical efficacy, safety, and long-term outcomes of percutaneous closure (PC) surgical repair ruptured sinus Valsalva aneurysm (RSVA). Methods Eighty-five consecutive patients with RSVA were included in this study. Patients considered candidates for PC if they met criterion, was performed on who unsuitable or failed PC. Of them, 30 underwent PC, while other 55 had repair. Results successfully occluded 29 treated by The mean narrowest diameter at site 6.45 ± 1.60 mm...

10.1111/chd.12572 article EN Congenital Heart Disease 2018-02-05

The impact of sildenafil on pulmonary arterial hypertension (PAH) in Chinese patients has been less investigated. A prospective, open‐label, uncontrolled and multicenter study, therefore, was carried out to address this issue. Ninety with multicause‐induced PAH received oral (75 mg/day) for 12 weeks. 6‐minute walk test (SMWT) cardiac catheterization were performed at the beginning end primary endpoint changes exercise capacity assessed by SMWT; secondary included assessment functional class,...

10.1177/0091270011398241 article EN The Journal of Clinical Pharmacology 2011-03-18

There is no generally accepted comprehensive risk prediction model cooperating factors associated with heart failure and pulmonary hemodynamics for patients hypertension due to left disease (PH-LHD). We aimed explore outcome correlates evaluate incremental prognostic value of in PH-LHD.Consecutive chronic undergoing right catheterization were prospectively enrolled. The primary endpoint was all-cause mortality. Individual variable selection performed by machine learning methods. Cox...

10.1186/s12872-022-02492-1 article EN cc-by BMC Cardiovascular Disorders 2022-02-16

Previous studies have demonstrated cardiac and vascular remodeling induced by microgravity exposure. Yet, as the most important branch of vasculatures circulating heart, coronary artery has been seldomly studied about its adaptations under conditions. Large‐conductance Ca 2+ ‐activated potassium channel (BK ) Ras homolog family member A (RhoA)/Rho kinase (ROCK) pathway play key roles in control tone mediation microgravity‐induced adjustments. Therefore, we investigated adaptation...

10.1096/fj.201901273r article EN The FASEB Journal 2019-09-17
Coming Soon ...